Central Institute Of Mental Health, Mannheim
Clinical trials sponsored by Central Institute Of Mental Health, Mannheim, explained in plain language.
-
Shock therapy maintenance may keep severe schizophrenia at bay
Disease control Recruiting nowThis study tests whether regular electroconvulsive therapy (ECT) sessions, given over time, can prevent a return of symptoms in people with schizophrenia that did not improve with the strongest medications. About 140 adults who already improved with a short course of ECT will eit…
Phase: NA • Sponsor: Central Institute of Mental Health, Mannheim • Aim: Disease control
Last updated May 13, 2026 16:04 UTC
-
Could CBD be the key to quieting alcohol cravings?
Symptom relief Recruiting nowThis study tests whether adding cannabidiol (CBD) to the standard medication naltrexone helps reduce alcohol cravings more than naltrexone alone. About 150 adults with alcohol addiction who experience strong cravings will take either a high or low dose of CBD plus naltrexone, or …
Phase: PHASE2 • Sponsor: Central Institute of Mental Health, Mannheim • Aim: Symptom relief
Last updated May 17, 2026 11:36 UTC
-
Brain training shows promise for calming emotional storms in BPD
Symptom relief Recruiting nowThis study tests a new approach for people with borderline personality disorder (BPD) who struggle with intense, unstable emotions. Using real-time brain scans, participants learn to calm an overactive emotion center in the brain. The goal is to see if this training reduces emoti…
Phase: PHASE1, PHASE2 • Sponsor: Central Institute of Mental Health, Mannheim • Aim: Symptom relief
Last updated May 05, 2026 11:56 UTC